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Abstract
Background: Brazil is an endemic country for schistosomiasis in the Latin American and Caribbean countries.
Pernambuco is a higher-endemic Brazilian state among the 19 states reporting the disease in the country;
schistosomiasis affects 102 (55%) of its 185 municipalities. Our objective was to evaluate the effectiveness of the
treatment cycles of the SANAR Program (Plan to Reduce and Eliminate Neglected Diseases) in Pernambuco State in
Northeast Brazil.
Methods: A cross-sectional population-based study was conducted in 2014 via a household survey in 117
hyperendemic locations in the state of Pernambuco. We compared the schistosomiasis prevalence rates in
hyperendemic locations, aggregated by geographical region, before and after the intervention. The dependent
variable was a positive stool test result by the Kato-Katz method, and the main exposure variable was the number
of treatment cycles (one/two). The covariables were the regions of the state and socioenvironmental,
socioeconomic, demographic and behavioral characteristics.
Results: In all, 12,969 individuals were interviewed, 8932 of whom had stool tests. Of these, 4969 (55.6%)
underwent two cycles of collective treatment. Changes in the environmental conditions since 2011 were minimal.
Comparison before (2011) and after (2014) treatment showed an average schistosomiasis prevalence of 18.6%,
decreasing to 4.1% and 2.0% in locations with one and two treatment cycles, respectively. In 2014, the highest
schistosomiasis prevalence was found in the forest area (2.8%), while the lowest was found in the northern region
(1.2%) of the state. The adjusted analysis showed a lower occurrence of schistosomiasis in individuals living in areas
with two treatment cycles than in individuals from areas with just one cycle (PR 0.65, 95% CI: 0.47–0.89).
Conclusions: The political decision made in Pernambuco to implement the SANAR Program in 2011 greatly
impacted the burden of schistosomiasis. This program was effective in reducing the occurrence of schistosomiasis
in hyperendemic areas in Pernambuco, with a stronger response in areas with two cycles of collective treatment.
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Background
Schistosomiasis is an infectious disease caused by
digenetic trematodes of the Schistosoma genus. In 2015,
schistosomiasis affected approximately 250 million
people worldwide [1]. The disease is transmitted by
Schistosoma mansoni in the Region of the Americas, and
Brazil and Venezuela present the highest endemicity
[2, 3]. Between 2.5 and 6 million people are currently
estimated to be infected with S. mansoni [4], and
700–800 deaths are reported annually in 19 Brazilian
endemic states [5, 6]. A recent systematic review and
meta-analysis reported that the prevalence of S. mansoni
infection in Brazil varied widely, from 0·1 to 73·1%, based
on the Kato-Katz technique [7].
Pernambuco is one of the states where schistosomiasis
is endemic; in Pernambuco, schistosomiasis affects 102
(55%) of the 185 municipalities, with regional differences
[8], and between 10 and 50% of test results are posi-
tive [9, 10]. The death and hospitalization rates related
to schistosomiasis are significantly higher in Pernambuco
than in other Brazilian states [11]. The low socioeconomic
level and scarcity of knowledge about the problem of
schistosomiasis increase the transmission of the disease,
particularly among children and adults, because of partici-
pation in recreational and occupational activities [12].
In addition to involving improved sanitation conditions
and treated drinking water availability [10, 13], the control
of schistosomiasis involves early diagnosis, timely
treatment, surveillance and educational actions [14]. In
endemic areas with positivity rates equal to or greater than
10%, schistosomiasis control using praziquantel is recom-
mended by means of large-scale treatment of the popula-
tion. The strategy of treating all individuals greater than
two years of age [15] is associated with a decrease in the
worldwide schistosomiasis occurrence [15, 16].
A single dose of medication is considered an effective
collective treatment and is a safe and low-cost strategy
for controlling all forms of schistosomiasis [17]. In 2014,
more than 60 million people were treated for schisto-
somiasis worldwide [18].
In keeping with World Health Organization (WHO)
proposals, in 2011, Brazil launched its Integrated
Strategic Action Plan for the Elimination of Neglected
Diseases [4]. In cooperation with state- and municipal-
level health service managers, the plan proposes the ac-
tive searching for and timely treatment of cases, consid-
ering, when indicated, collective treatment interventions
in locations with positive test results in more than 25%
of the population [14]. In 2011, the Pernambuco State
Health Department launched the SANAR Program to
reduce and/or eliminate the following neglected diseases:
schistosomiasis, tuberculosis, leprosy, Chagas disease,
leishmaniasis, filariasis, geohelminthiases and trachoma.
SANAR is the first initiative of the integrated plan at the
state level to develop a specific program for combating
schistosomiasis by including collective treatment. The
main integrated SANAR actions were community educa-
tion and environmental assessment in hyperendemic
areas for schistosomiasis [10, 19], supplemented by
household collective treatment. At the management
level, the program established guidelines, goals and
indicators that were routinely monitored as part of the
priority actions of the Pernambuco State Government
[20, 21]; these parameters were associated with the train-
ing of health workers, particularly primary health care
teams, community health workers, and personnel from
endemic control, health surveillance, information sys-
tems, and laboratory organizations [22].
In contrast with the national reference and in line with
the WHO recommendations [15], the political decision
made in Pernambuco was to maximize the effectiveness
of intervention; to this end, the Pernambuco State
Health Department adopted collective treatment for
areas where the schistosomiasis prevalence in the popu-
lation was greater than 10%. This intervention was inte-
grated with selective treatment involving family health
teams that was made available also in endemic areas
with prevalence rates below 10% [23].
Given the social relevance of the SANAR Program to
reduce and eliminate schistosomiasis as a neglected dis-
ease, this article aims to evaluate the effectiveness of this
program according to the collective treatment cycles. To
contextualize the relevance of the findings of the effect-
iveness study, we previously assessed the trends for
disease positivity, treatment, hospitalization and mortality
during the period 2010–2014 both in Pernambuco and in
Brazil.
Methods
Schistosomiasis trends in Pernambuco and in Brazil
The trend study was conducted based on secondary data
routinely collected in Brazil and obtained from health
information systems. The data on the positivity of tests
performed to confirm schistosomiasis and on the treat-
ment of confirmed cases were provided by the Informa-
tion System for Notifiable Diseases (SINAN), the data
on hospitalization owing to schistosomiasis were ob-
tained from the Hospital Information System (SIH-SUS),
and the data on deaths due to schistosomiasis (B65 −
ICD-10) were obtained from the Mortality Information
System (SIM). The data in the three databases were both
for the state of Pernambuco and for the country of
Brazil for the same period: 2010–2014.
SANAR program: selection of locations for collective
treatment interventions
Based on the Schistosomiasis Control Program Information
System (SIS-PCE/SES-PE), a total of 119 hyperendemic
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locations in rural and urban areas of 30 priority municipal-
ities were identified in the state of Pernambuco for the
years 2010 and 2011. The municipalities that had a mean
prevalence of 10% or more between 2005 and 2010 were
included in the program [23]. In each endemic municipal-
ity, all locations with a schistosomiasis prevalence greater
than or equal to 10% were included [24].
In the 119 locations selected, three cycles of collective
treatment using chemotherapy were planned to take
place, with a minimum planned coverage of 80% of the
target population. In 2012 and 2013, 61 (52.1%)
locations received one treatment cycle and 56 (47.9%)
received two cycles. Approximately 70% of the
locations had a mean coverage greater than 70%
(lower: southern = 67%; higher: metropolitan zone =
79%), with a median coverage of 79%.
Praziquantel manufactured by Farmanguinhos was
used for treatment at a dose of 50 mg per kilo of body
weight (mg/kg) for people over 15 years old and 60 mg/kg
for children between two and 15 years old. The recom-
mended dosage is different because of differences in the
metabolism of adults and children. Praziquantel was pro-
vided in tablet format and administered orally in a single
dose. Adverse effects are slight, and there is no evidence
that praziquantel produces serious toxic lesions of the
liver or other organs [2, 15, 24].
Effectiveness evaluation survey
In September and October 2014, a cross-sectional
population-based study was conducted via a household
survey to evaluate the performance of the SANAR pro-
gram in relation to schistosomiasis in 117 hyperendemic
locations. The survey compared the schistosomiasis preva-
lence rates before and after the intervention in hyperen-
demic locations aggregated by geographical region. The
sampling process selected a representative sample in all
regions with endemic areas stratified by the number of
collective treatments performed. A starting point was
chosen in each locality, and from this starting point, a sys-
tematic sample of households was included. The quota
was proportional to the size of the locality. The higher/
lower the population of the locality, the higher/lower was
the number of households selected. The number itself was
based on this proportionality and on the final intended
sample size. The final sample population was 11,842. All
individuals in each household aged over two years old
were included. Pregnant women were excluded.
The data were collected by health surveillance
personnel from the State Health Department of Pernam-
buco using handheld computers following one week of
training. If an eligible family member was absent, the
data for that individual were obtained from a key in-
formant. At the same time as the data collection, marked
plastic containers were provided for the collection of
stool samples from the household the next day. The
samples were kept on ice in Styrofoam coolers. On the
third day, the coolers were delivered to the laboratory,
where they were stored in refrigerators until the prepar-
ation and reading of microscope slides. Laboratory
analysis took place between the first week of September
and the end of October 2014. Before being read under a
microscope, the slides were prepared by mid-level
professional staff at the schistosomiasis laboratory of the
municipality of Jaboatão dos Guararapes-PE. The
Kato-Katz method was used [25]. This predominant
method for detecting S. mansoni eggs is relatively
straightforward, inexpensive and highly specific [26–29].
Valid stool samples were those for which the stool quan-
tity was sufficient to allow the sample to be processed
via the Kato-Katz method. Some of the collection con-
tainers delivered had no stool, only a small amount of
stool, or stool of a liquid or pasty consistency, which
prevented processing for slide preparation. The test re-
sults were read by biologists from the State Laboratory
of Public Health working for the schistosomiasis control
program. The results were recorded on the epidemio-
logical surveillance field form and sent for processing at
the State Health Department. After input, copies of the
forms were sent to the municipalities to be entered into
the SISPCE and to allow the treatment of positive cases.
The dependent variable was a positive stool test result
for Manson’s schistosomiasis, and the main exposure
variable was the number of treatment cycles (one/two).
The other exposure variables were the following: “region
of the state” (northern (Agreste Setentrional)/metropol-
itan/southern (Agreste Meridional)/forest area (Zona da
Mata)); “zone of residence”; the presence of open drain-
age ditches/sewers; “positive house flooding status”;
“economic status” according to the Brazilian Association
of Studies and Research (B and C/D/E); “sex” (female/
male); “age” (< 5/5–14 years/15–44 years/45 years or
over); “skin color or race” (Caucasian, Afro-Brazilian,
Asian, Mixed/Pardo Brazilian, Amerindian); “cohabit-
ation status”; “contact with river water”; “contact with
water from open drainage ditches/sewers”; “walking
barefoot in the street”; and “schistosomiasis occurrence
at some time in life”.
The raw and adjusted analyses were performed using
Poisson regression with robust variance adjustment [30].
The adjusted analysis aimed to evaluate the effect of the
number of treatment cycles on the occurrence of schis-
tosomiasis. To this end, a hierarchical analysis model
was used with the aim of determining which variables
influenced the association. The adjusted analyses
comprised four levels (adjustment 1: “region of the state”
and “zone of residence”; adjustment 2: “positive house
flooding status” and “economic status”; adjustment 3:
“sex”, “age” and “skin color”; adjustment 4: “contact with
Facchini et al. BMC Public Health         (2018) 18:1200 Page 3 of 11
river water” and “schistosomiasis occurrence at some
time in life”).
Results
Schistosomiasis trends in Pernambuco and in Brazil
Almost 100,000 and 1,382,785 tests to assess for schisto-
somiasis positivity were performed in Pernambuco and
Brazil, respectively, in 2010; 256,809 and 814,905 tests
were performed in Pernambuco and Brazil, respectively,
in 2014. Schistosomiasis positivity was 8.31% in 2010
and 3.39% in 2014 in the state of Pernambuco (during
these same years, the positivity decreased from 5.02 to
4.07% in Brazil). In Pernambuco, the proportion of
individuals with positive test results who were treated
increased, while in Brazil, this proportion decreased. The
rate of hospitalization from schistosomiasis (per 100,000
inhabitants) decreased in both Pernambuco and Brazil.
The schistosomiasis mortality rate in Pernambuco de-
creased from 2.23 (per 100,000 inhabitants) in 2010 to
1.51 in 2014. The total mortality rate for Brazil was 0.27
in 2010 and 0.24 in 2014 (Please see Table 1).
Effectiveness evaluation survey
A total of 12,969 individuals were interviewed; valid
stool samples were collected for evaluation from 8932
(68.9%) of these. Among the infected study subjects
(n = 197), the mean number of eggs per slide was 7.9
(189.3 per gram), the median was 2 per slide (48 per
gram), the interquartile interval per slide was 1–6
(24–144 per gram), and 52.3% of the subjects pre-
sented 1 or 2 eggs per slide by examination (more
than 48 eggs per gram). A total of 4969 (55.6%) of
the individuals underwent two treatment cycles. The for-
est area (Zona da Mata) region had the highest propor-
tion of interviewees (31.7%). Half of the interviewed
individuals lived in the urban zone. A total of 41.2% of the
individuals lived in locations with open drainage ditches/
sewers that had been corrected in fewer than 3% of these
locations. Water usually flooded the houses of 11.2% of
the individuals, while 27.5% reported that there had never
been flooding where they lived. Only 3.1% stated that the
flooding situation had improved since 2011. The majority
of the interviewees were of economic status D (58.8%).
Half of the sample was female, and half was aged 15–44.
The most commonly reported skin color was brown
(62.3%), and 45.9% reported having a partner. Almost
one-third reported having current contact with river water
(28.7%) and with water from open drainage ditches/sewers
(33.4%). Less than 15.0% stated that they always walked
barefoot in the street, and 61.9% stated that they never did
Table 1 Indicators of schistosomiasis positivity, hospitalization and mortality in Pernambuco and Brazil, 2010–2014
Indicators Pernambuco Brazil
2010 2011 2012 2013 2014 2014/2010 2010 2011 2012 2013 2014 2014/2010
Diagnosis and treatment
Tests performedb 98,561 103,880 94,384 120,171 256,809 2.61 1,382,785 1,267,247 878,751 795,174 814,905 0.59
Positive result 8186 7623 5336 6509 8713 – 69,436 59,946 38,685 36,994 33,193 –
Positivity (%) 8.31 7.34 5.65 5.42 3.39 0.41 5.02 4.73 4.4 4.65 4.07 0.81
Treated 6500 6027 4300 5197 7104 – 61,820 52,238 29,506 28,272 26,042 –




78 62 53 33 41 – 301 240 218 163 175 –
Hospitalization rate
(per 100,000 inhab.)




196 174 158 141 140 – 514 546 488 468 480 –








2.23 1.96 1.77 1.53 1.51 0.68 0.27 0.28 0.25 0.23 0.24 0.88
aTotal population - Pernambuco, 2010: 8796032, 2011: 8864906, 2012: 8931028, 2013: 9208550, 2014: 9277727; Brazil: 2010: 190747855, 2011: 192379287, 2012:
193946886, 2013: 201032714, 2014: 202768562
bPopulation accessed - Pernambuco, 2010: 137363, 2011: 140503, 2012: 133990, 2013: -, 2014: 358954; Brazil, 2010: 1849983, 2011: 1709702, 2012: 1205789, 2013:
1111304, 2014: 1127632
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this. A diagnosis of schistosomiasis at some time in life
was reported by 17.1% of the interviewees (Please see
Table 2).
The highest schistosomiasis prevalence among all four
regions was found in the forest area (Zona da Mata)
(2.8%, p = 0.001). The schistosomiasis prevalence in areas
with two treatment cycles was 30% lower than that in
areas with just one treatment cycle (p = 0.011). Individ-
uals who lived in homes that flooded, were of economic
status E, were male, were aged 15–44, stated that their
skin color was black or brown, and had current and past
contact with river water presented a higher prevalence
of schistosomiasis. Of the interviewees, 17.1% stated that
they had been diagnosed with schistosomiasis at some
time in their lives (Please see Table 2). Those who had
had the disease stated that the main symptoms were
abdominal pain (47%) and feeling sick (35%).
The schistosomiasis prevalence in areas with two treat-
ment cycles was approximately 35% lower than that in
locations with just one treatment cycle, even after the
adjustments (Please see Table 3).
Generally, before treatment, 64.4% of the locations had
schistosomiasis prevalence rates of between 10 and
19.9%, whereas 31.4% had prevalence rates of 20% or
greater. In areas with one and two treatment cycles, this
proportion decreased to 13.1% and 5.4%, respectively.
More robust reductions were found in the southern and
northern regions than in the other regions. After two
cycles of collective treatment, 64.3% of the locations
studied had a schistosomiasis prevalence equal to zero
(Please see Fig. 1). The average schistosomiasis preva-
lence was 18.6% at baseline, decreasing to 4.1% and 2.0%
in areas with one and two treatment cycles, respectively
(Please see Fig. 2).
Discussion
SANAR provide a tested example for Brazil to com-
pose its response to Sustainable Development Goals
(SDGs). For the first time, the global agenda faces the
explicit challenge to end epidemics of neglected trop-
ical diseases by 2030, among other targets related to
Goal 3: ensure healthy lives and promote well-being
for all at all ages [31].
Repeated treatment during childhood and adolescence
persists into adulthood, reducing the chronic evolution
of schistosomiasis in hyperendemic areas, thus increas-
ing the quality of life. Accurate monitoring in the next
decade is essential to control not only the morbidity but
also the mortality and severity of the disease, strengthen-
ing the effect of large-scale preventive chemotherapy
regimens [32].
SANAR has provided new protocols and strategies for
health surveillance actions for schistosomiasis in the
state of Pernambuco, emphasizing the relevance of
neglected tropical diseases in the political agenda of the
state government. The overall cost of specific interven-
tions for schistosomiasis to the state government,
including the actions of the SANAR Program, was
approximately US$ 308,081 in the period from 2011 to
2014, or about US$ 6000 per month; these expenses in-
cluded inputs, printed matter, equipment, personnel
wages, consultancies, training, and fuel. Through the
Integrated Strategic Action Plan for the Elimination of
Neglected Diseases, the Ministry of Health freely delivers
praziquantel to the municipalities to guarantee collective
treatment in the priority areas [4]. Unfortunately, the
country’s current political scenario of funding restric-
tions on health policies for the next 20 years is threaten-
ing the program’s sustainability [33].
In keeping with the global trend of reduced schisto-
somiasis occurrence, which was estimated to be 23.5%
between 2005 and 2015 [1], the detection of positive
cases was found to have decreased in Brazil as a whole
and in Brazilian states with high endemicity such as
Pernambuco [11]. When the secondary data were used
to analyze the timespan from 2010 to 2014 in Pernam-
buco, the reduction was significantly greater than that in
Brazil and in the states of Sergipe and Alagoas (two
states neighboring Pernambuco with similar schistosom-
iasis endemicity) [5]. The success achieved in controlling
schistosomiasis in Pernambuco, compared to that
achieved in the national and regional context, can essen-
tially be attributed to the SANAR Program, which has
not yet been implemented in the country’s other states.
The possibility of comparing Pernambuco’s results with
those achieved in Brazil as a whole and in neighboring
states is a natural experiment [34]. An important part of
the achievement attains plausibility via the adoption of
collective treatment in locations with a prevalence
greater than 10%, as recommended by the WHO [15],
instead of the implementation of the Brazilian Ministry
of Health’s recommendation, which is based on a preva-
lence of greater than 25% as the cutoff point for collect-
ive interventions [4].
When the primary data related to the biological mater-
ial collected was evaluated, a beneficial effect of collect-
ive treatment was found in the reduction of positive
schistosomiasis cases in hyperendemic locations. After
two treatment cycles had been performed, approximately
nine of every ten locations had a schistosomiasis preva-
lence of < 10%, the limit defined by the WHO as a low
community risk for the propagation of the disease [35].
The finding that a higher number of treatment cycles
had a protective effective on schistosomiasis occurrence
in priority locations in Pernambuco reinforces the ability
to control the disease in hyperendemic locations by
means of collective treatment integrated with primary
health care service actions, particularly the Family
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Table 2 Sample characteristics, schistosomiasis prevalence and raw analysis according to independent variables. Pernambuco,
Brazil, 2014




Number of treatment cycles 0.011
1 3963 44.4 2.7 1.00
2 4969 55.6 1.9 0.70 0.53 0.92
Region 0.001
Northern (Agreste Setentrional) 2415 27.0 1.2 1.00
Metropolitan 2400 26.9 2.5 2.12 1.37 3.28
Southern (Agreste Meridional) 1290 14.4 2.1 1.74 1.04 2.93
Forest area (Zona da mata) 2827 31.7 2.8 2.36 1.55 3.59
Zone of residence 0.105
Urban 4878 55.0 2.4 1.00
Rural 3992 45.0 1.9 0.79 0.60 1.05
Open drainage ditch/sewer 0.999
No 5168 58.9 2.2 1.00
Yes 3614 41.2 2.2 1.00 0.75 1.33
Was there an open drainage ditch/sewer that was corrected after 2011? 0.860
No 8535 97.2 2.2 1.00
Yes 247 2.8 2.0 0.92 0.38 2.23
Does water usually flood houses? 0.039
Yes 981 11.2 2.8 1.00
No 5380 61.3 2.4 0.86 0.57 1.30
There has never been a flood 2417 27.5 1.6 0.57 0.35 0.93
Was there flooding, but the situation improved after 2011? 0.114
No 8505 96.9 2.3 1.00
Yes 273 3.1 0.7 0.33 0.08 1.31
Economic status 0.001
B and C 2739 33.5 2.3 1.00
D 4801 58.8 2.0 0.86 0.63 1.19
E 626 7.7 4.3 1.91 1.22 2.97
Sex 0.020
Female 4860 54.4 1.9 1.00
Male 4072 45.6 2.6 1.39 1.05 1.83
Age (full years) 0.002
< 5 738 5.7 0.6 1.00
5–14 2746 21.2 1.6 2.42 0.74 7.91
15–44 6335 48.9 2.8 4.35 1.39 13.6
45 or over 3145 24.2 2.0 3.11 0.97 9.96
Skin color 0.021
White 2443 27.5 1.5 1.00
Black 848 9.5 3.2 2.10 1.29 3.43
Brown 5546 62.3 2.4 1.57 1.09 2.26
Yellow/indigenous 63 0.7 1.6 1.05 0.15 7.52
Lives with a partner 0.421
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Health Strategy [36, 37]. Although socioenvironmental
changes are one of the most important determinants of
schistosomiasis [13, 37], few such changes occurred
during the period of the SANAR Program activities [21],
thus reducing the possibility that an environmental ef-
fect explains the reduction in schistosomiasis prevalence.
In terms of health impacts and cost-effectiveness,
few interventions rival collective treatment of
neglected diseases integrated with primary health
care. In addition to its relevance for people with
schistosomiasis, this treatment approach has been in-
creasingly recognized for its beneficial effects on
strengthening health systems and on economic de-
velopment [38].
Despite the relevance of the finding regarding the
effectiveness of the intervention spearheaded by the
SANAR Program, the evidence also shows that collective
treatment alone is not sufficient to eliminate the disease.
The SANAR Program promoted the integration of
collective actions with Pernambuco’s primary health
network, particularly with multidisciplinary family health
teams. As the main expression of the Integrated
Strategic Action Plan for the Elimination of Neglected
Diseases in the state of Pernambuco, the SANAR
Program intervention had a marked effect on increasing
the number of people examined and treated between
2011 and 2014 [4].
The evidence from this study points to the relevance
of continuing to monitor hyperendemic regions along
with strengthening vector control and health services,
the contribution of which to the effectiveness of the
SANAR Program deserves to be evaluated in depth.
Table 2 Sample characteristics, schistosomiasis prevalence and raw analysis according to independent variables. Pernambuco,
Brazil, 2014 (Continued)




No 4832 54.1 2.1 1.00
Yes 4100 45.9 2.3 1.12 0.85 1.48
Has contact with water from rivers < 0.001
No, never 2263 25.6 1.1 1.00
Yes, in the past but not currently 4046 45.7 2.6 2.30 1.49 3.56
Yes, currently 2537 28.7 2.7 2.46 1.56 3.88
Has contact with water from open drainage ditches/sewers 0.627
No, never 4180 47.3 2.2 1.00
Yes, in the past but not currently 1705 19.3 2.5 1.11 0.77 1.59
Yes, currently 2950 33.4 2.0 0.91 0.66 1.26
Walks barefoot in the street 0.999
Never 5509 61.9 2.2 1.00
Sometimes 1714 19.3 2.2 1.01 0.70 1.45
Nearly always 526 5.9 2.3 1.04 0.58 1.87
Always 1154 13.0 2.2 0.99 0.64 1.51
Has had schistosomiasis at some time in life 0.193
No 7107 82.9 2.1 1.00
Yes 1467 17.1 2.7 1.26 0.89 1.78
Table 3 Raw and adjusted analyses of the association between




Raw analysis 0.70 0.53–0.92 0.011
Adjustment 1 0.64 0.47–0.87 0.005
Adjustment 2 0.58 0.42–0.81 0.001
Adjustment 3 0.61 0.44–0.83 0.002
Adjustment 4 0.65 0.47–0.89 0.008
aReference group: 1st treatment cycle; Exposed group: 2nd treatment cycle
Adjustment 1: region of the state and zone of residence
Adjustment 2: Adjustment 1 + positive house flooding status and economic
status (ABEP)
Adjustment 3: Adjustment 2 + sex, age and skin color
Adjustment 4: Adjustment 3 + contact with river water + schistosomiasis at
some time in life
PR prevalence ratio. 95% CI 95% confidence interval. p-value: Wald’s
heterogeneity test
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Nevertheless, it is essential to reaffirm the key nature of
implementing substantial environmental improvements
in order to permanently eliminate and/or control schis-
tosomiasis, thus valuing the quality of life and dignity of
the population and, even more importantly, addressing
the social determinants of the problem [10, 13, 22, 37].
Some authors [12] suggest that environmental changes
can be more feasible if funding for programs to address
neglected diseases includes allocating part of the re-
sources to health activities, including the purchase and
distribution of medication, and allocating another part
of the resources to investments in extending treated
drinking water networks and adequate sanitation and in
improving living conditions [37].
The relevance of the socioenvironmental determinants
of the problem is reinforced by noting that the overall
Fig. 1 Schistosomiasis prevalence intervals by treatment cycle and region. Pernambuco, Brazil, 2011-2014
Fig. 2 Schistosomiasis prevalence by treatment cycle and region. Pernambuco, Brazil, 2011-2014
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success of the SANAR Program did not overcome the
geographical context. The findings indicate that coastal
regions and regions near watercourses (forest area/Zona
da Mata), continue to have the highest prevalence rates
and have higher proportions of locations with prevalence
rates above 10% than do other regions [8, 12].
Although the study included poor and vulnerable
locations, socioeconomic differences were strongly
associated with the occurrence of schistosomiasis, thus
highlighting the relevance of accounting for the hetero-
geneity of the population, even in locations considered
to be contextually similar.
Some limitations of this study need to be considered.
First, it was not possible to select the same individuals
before and after collective treatment, which may have di-
luted the effect of treatment. However, given the large
differences found, we do not believe that this limitation
influenced the results in a significant manner. Second,
the use of the Kato-Katz method to diagnose schisto-
somiasis in areas of low endemicity has been questioned.
Some authors suggest that more sensitive techniques,
such as ELISA, should be used [26]. However, the pro-
longed presence of reactive IgM after treatment and the
death of the worms is a critical problem in evaluating
the effectiveness of an intervention. We suggest that
more sensitive techniques be used in future studies in
high endemicity areas that become low prevalence areas
following collective treatment in order to monitor
changes via the complementary use of more sensitive
techniques such as serial stool tests. Another limitation
is that schistosomiasis surveys in the untreated locations,
which could be used as controls, were not conducted.
Furthermore, information on the snail vectors and their
infection status in the study area is lacking.
The SANAR Program demonstrated effectiveness in
controlling schistosomiasis in areas with high endem-
icity, so its implementation in other regions of Brazil
and across the world can be recommended via adopting
collective treatment in areas with a positive test preva-
lence in 10% or more of the population. The integrated
action of the SANAR Program with the Family Health
Strategy augments the interaction of the effects arising
from collective treatment, prevention, surveillance and
selective treatment. Despite the short time during which
the Program has been implemented, its benefits for the
population go beyond the significant reduction in the
number of individuals with positive schistosomiasis test
results, extending to a reduction in hospitalization and
mortality from this disease.
Conclusions
The political decision made in Pernambuco to imple-
ment the SANAR Program in 2011 greatly impacted the
burden of schistosomiasis. The program promoted an
effective reduction in the occurrence of schistosomiasis
in hyperendemic areas in Pernambuco. The response
was stronger in areas with two cycles of collective treat-
ment than in one-cycle areas. The SANAR Program
should be evaluated by other Brazilian states and even
globally as a successful strategy for facing the challenge
of neglected diseases.
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